DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,196 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,858,884 | +0.1% | 7,440 | 0.0% | 0.13% | +0.8% |
Q1 2024 | $1,857,917 | -0.9% | 7,440 | -8.2% | 0.12% | -6.0% |
Q4 2023 | $1,874,779 | -8.0% | 8,104 | -1.3% | 0.13% | -13.6% |
Q3 2023 | $2,037,397 | +4.6% | 8,212 | +1.2% | 0.15% | +8.5% |
Q2 2023 | $1,946,880 | +26.4% | 8,112 | +32.7% | 0.14% | +20.3% |
Q1 2023 | $1,540,469 | +21.8% | 6,112 | +28.8% | 0.12% | +15.7% |
Q4 2022 | $1,264,249 | +3.1% | 4,747 | -0.0% | 0.10% | -6.4% |
Q3 2022 | $1,226,000 | -36.0% | 4,748 | -37.2% | 0.11% | -30.6% |
Q2 2022 | $1,916,000 | -6.4% | 7,558 | +8.4% | 0.16% | +6.1% |
Q1 2022 | $2,046,000 | -15.5% | 6,975 | -5.2% | 0.15% | -11.4% |
Q4 2021 | $2,421,000 | +13.4% | 7,358 | +4.3% | 0.17% | +3.7% |
Q3 2021 | $2,134,000 | +12.7% | 7,058 | 0.0% | 0.16% | +12.6% |
Q2 2021 | $1,894,000 | +19.3% | 7,058 | 0.0% | 0.14% | +15.3% |
Q1 2021 | $1,588,000 | +1.3% | 7,058 | 0.0% | 0.12% | -0.8% |
Q4 2020 | $1,568,000 | +3.2% | 7,058 | 0.0% | 0.12% | -4.6% |
Q3 2020 | $1,520,000 | +21.8% | 7,058 | 0.0% | 0.13% | +18.0% |
Q2 2020 | $1,248,000 | -12.7% | 7,058 | -31.7% | 0.11% | -22.4% |
Q1 2020 | $1,430,000 | +0.6% | 10,333 | +11.6% | 0.14% | +22.2% |
Q4 2019 | $1,421,000 | -8.1% | 9,262 | -13.5% | 0.12% | -7.9% |
Q3 2019 | $1,547,000 | -3.2% | 10,712 | -4.2% | 0.13% | -3.8% |
Q2 2019 | $1,598,000 | +8.3% | 11,179 | 0.0% | 0.13% | +6.5% |
Q1 2019 | $1,476,000 | +28.8% | 11,179 | +0.6% | 0.12% | +14.8% |
Q4 2018 | $1,146,000 | +0.9% | 11,109 | +6.2% | 0.11% | +14.9% |
Q3 2018 | $1,136,000 | +3.6% | 10,459 | -5.9% | 0.09% | -4.1% |
Q2 2018 | $1,096,000 | +2.6% | 11,109 | +1.8% | 0.10% | +1.0% |
Q1 2018 | $1,068,000 | +8.4% | 10,909 | +2.8% | 0.10% | +14.1% |
Q4 2017 | $985,000 | +0.6% | 10,609 | -7.0% | 0.08% | -2.3% |
Q3 2017 | $979,000 | +1.8% | 11,409 | 0.0% | 0.09% | -1.1% |
Q2 2017 | $962,000 | -1.4% | 11,409 | 0.0% | 0.09% | -2.2% |
Q1 2017 | $976,000 | +9.9% | 11,409 | 0.0% | 0.09% | +7.1% |
Q4 2016 | $888,000 | -0.8% | 11,409 | 0.0% | 0.08% | +2.4% |
Q3 2016 | $895,000 | -37.8% | 11,409 | -20.0% | 0.08% | -37.4% |
Q2 2016 | $1,439,000 | +12.8% | 14,254 | +5.9% | 0.13% | +11.0% |
Q1 2016 | $1,276,000 | +2.1% | 13,454 | 0.0% | 0.12% | -1.7% |
Q4 2015 | $1,250,000 | +9.1% | 13,454 | 0.0% | 0.12% | +4.3% |
Q3 2015 | $1,146,000 | -0.5% | 13,454 | 0.0% | 0.12% | +7.5% |
Q2 2015 | $1,152,000 | +26.7% | 13,454 | +25.7% | 0.11% | +28.9% |
Q1 2015 | $909,000 | -0.9% | 10,704 | 0.0% | 0.08% | +2.5% |
Q4 2014 | $917,000 | +7.8% | 10,704 | -4.5% | 0.08% | +6.6% |
Q3 2014 | $851,000 | -7.2% | 11,204 | -3.8% | 0.08% | -3.8% |
Q2 2014 | $917,000 | – | 11,646 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |